KAITLIN COLELLA: Open Payments
NPI 1437570827 · WINDERMERE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 10 payments from 6 companies in 2025. Trend: 2023 $1,130 · 2024 $1,046 · 2025 $1,142
Food & beverage: $917Consulting: $225
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $458 |
| Janssen Biotech, Inc. | 2 | $267 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Lucid Diagnostics Inc. | 2 | $140 |
| Phathom Pharmaceuticals, Inc. | 1 | $116 |
| ABBVIE INC. | 1 | $16 |
Products named: XIFAXAN, TREMFYA, REZDIFFRA, VOQUEZNA, CREON.
Industry payments across FL — which companies pay providers there.
